Literature DB >> 15313681

A rabbit model of non-cirrhotic portal hypertension by repeated injections of E.coli through indwelling cannulation of the gastrosplenic vein.

Swati Omanwar1, Moattar R Rizvi, Rachna Kathayat, Brij K Sharma, Giryesh K Pandey, Mohammad A Alam, Giryesh K Pandey, Veena Malhotra, Shiv K Sarin.   

Abstract

BACKGROUND: Non-cirrhotic portal hypertension is a common cause of portal hypertension in developing countries. To understand its etiopathogenesis we developed an animal model by repeated portal endotoxemia induced through the gastrosplenic vein.
METHODS: Twenty-nine rabbits (1.5-2.0 kg) were divided into control (group I, n=13) and experimental (group II, n=16) groups. Heat killed E.coli were injected through an indwelling cannula into the gastrosplenic vein in pre-sensitized animals. The animals were sacrificed at 1, 3 and 6 months.
RESULTS: The mean portal pressure in group II animals was significantly (P<0.05) higher than in group I at 1 (17.5+/-3.4 vs 10.4+/-2.2 mmHg), 3 (17.8+/-1.3 vs 7.2+/-3.6 mm Hg), and 6 (19.8+/-3.1 vs 10.3+/-4.8 mmHg) months. Similarly, the mean splenic weight in group II was significantly greater than in group I (P<0.05). Histopathologically, the spleen showed medullary congestion, hemosidrin-laden macrophages and mild fibrosis. Histologically, the liver had normal parenchyma with mild portal lymphocytic infiltrates and kupffer cell hyperplasia. No significant anomalies were detected by liver function tests.
CONCLUSIONS: The rabbit model showed significant splenomegaly with a persistent increase in portal pressure and mild fibrosis without hepatic parenchymal injury, quite akin to non-cirrhotic portal fibrosis as seen in humans. Recurrent intra-abdominal infection may play an important role in the pathogenesis of non-cirrhotic portal fibrosis.

Entities:  

Mesh:

Year:  2004        PMID: 15313681

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  6 in total

Review 1.  Idiopathic portal hypertension and extrahepatic portal venous obstruction.

Authors:  Rajeev Khanna; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2018-02-20       Impact factor: 6.047

2.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Yogesh Kumar Chawla; Sanjay Saran Baijal; Radha Krishna Dhiman; Wasim Jafri; Laurentius A Lesmana; Debendranath Guha Mazumder; Masao Omata; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2007-09-11       Impact factor: 6.047

Review 3.  The portal hypertension syndrome: etiology, classification, relevance, and animal models.

Authors:  Jaime Bosch; Yasuko Iwakiri
Journal:  Hepatol Int       Date:  2017-10-24       Impact factor: 6.047

4.  Nitric oxide and prostaglandin as mediators in the pathogenesis of hyperkinetic circulatory state in a model of endotoxemia-induced portal hypertension.

Authors:  Moattar Raza Rizvi; Mohammad Tauseef; Mohd Shahid; Rashmi Babbar; Mohammad Fahim; Puja Sakhuja; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2012-09-02       Impact factor: 6.047

Review 5.  What makes non-cirrhotic portal hypertension a common disease in India? Analysis for environmental factors.

Authors:  Ashish Goel; Banumathi Ramakrishna; Uday Zachariah; K G Sajith; Deepak K Burad; Thomas A Kodiatte; Shyamkumar N Keshava; K A Balasubramanian; Elwyn Elias; C E Eapen
Journal:  Indian J Med Res       Date:  2019-04       Impact factor: 2.375

6.  Prenatal endotoxemia and placental drug transport in the mouse: placental size-specific effects.

Authors:  Enrrico Bloise; Manzerul Bhuiyan; Melanie C Audette; Sophie Petropoulos; Mohsen Javam; William Gibb; Stephen G Matthews
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.